vs
Mirum Pharmaceuticals, Inc.（MIRM）与T1 Energy Inc.（TE）财务数据对比。点击上方公司名可切换其他公司
T1 Energy Inc.的季度营收约是Mirum Pharmaceuticals, Inc.的1.4倍（$210.5M vs $148.9M），Mirum Pharmaceuticals, Inc.净利率更高（-3.8% vs -62.0%，领先58.2%），T1 Energy Inc.自由现金流更多（$55.0M vs $5.5M）
Mirum Pharmaceuticals是一家处于后期阶段的生物制药企业，专注于为存在高度未满足医疗需求的罕见重症肝病患者开发及商业化创新治疗方案，服务覆盖北美、欧洲等全球多个地区的成人与儿童患者群体。
索尼能源设备株式会社是隶属于索尼集团设备事业部的全资子公司，是一家日本跨国企业，深耕能源产业多领域业务。该公司1975年2月在日本福岛成立，依托索尼的技术积累，在能源相关产品研发、生产及商业化方面具备行业领先实力。
MIRM vs TE — 直观对比
营收规模更大
TE
是对方的1.4倍
$148.9M
净利率更高
MIRM
高出58.2%
-62.0%
自由现金流更多
TE
多$49.5M
$5.5M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $148.9M | $210.5M |
| 净利润 | $-5.7M | $-130.6M |
| 毛利率 | — | 10.0% |
| 营业利润率 | -3.1% | -45.0% |
| 净利率 | -3.8% | -62.0% |
| 营收同比 | 49.8% | — |
| 净利润同比 | 75.9% | -375.2% |
| 每股收益（稀释后） | $-0.10 | $-0.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MIRMTE
| Q4 25 | $148.9M | — | ||
| Q3 25 | $133.0M | $210.5M | ||
| Q2 25 | $127.8M | $132.8M | ||
| Q1 25 | $111.6M | $53.5M | ||
| Q4 24 | $99.4M | — | ||
| Q3 24 | $90.4M | $0 | ||
| Q2 24 | $77.9M | $0 | ||
| Q1 24 | $69.2M | $0 |
净利润MIRMTE
| Q4 25 | $-5.7M | — | ||
| Q3 25 | $2.9M | $-130.6M | ||
| Q2 25 | $-5.9M | $-31.9M | ||
| Q1 25 | $-14.7M | $-16.2M | ||
| Q4 24 | $-23.8M | — | ||
| Q3 24 | $-14.2M | $-27.5M | ||
| Q2 24 | $-24.6M | $-27.0M | ||
| Q1 24 | $-25.3M | $-28.5M |
毛利率MIRMTE
| Q4 25 | — | — | ||
| Q3 25 | — | 10.0% | ||
| Q2 25 | — | 24.7% | ||
| Q1 25 | — | 33.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率MIRMTE
| Q4 25 | -3.1% | — | ||
| Q3 25 | 2.0% | -45.0% | ||
| Q2 25 | -3.9% | -22.0% | ||
| Q1 25 | -13.6% | -44.2% | ||
| Q4 24 | -24.4% | — | ||
| Q3 24 | -14.0% | — | ||
| Q2 24 | -31.1% | — | ||
| Q1 24 | -38.2% | — |
净利率MIRMTE
| Q4 25 | -3.8% | — | ||
| Q3 25 | 2.2% | -62.0% | ||
| Q2 25 | -4.6% | -24.0% | ||
| Q1 25 | -13.2% | -30.4% | ||
| Q4 24 | -23.9% | — | ||
| Q3 24 | -15.8% | — | ||
| Q2 24 | -31.6% | — | ||
| Q1 24 | -36.5% | — |
每股收益（稀释后）MIRMTE
| Q4 25 | $-0.10 | — | ||
| Q3 25 | $0.05 | $-0.87 | ||
| Q2 25 | $-0.12 | $-0.21 | ||
| Q1 25 | $-0.30 | $-0.11 | ||
| Q4 24 | $-0.49 | — | ||
| Q3 24 | $-0.30 | $-0.20 | ||
| Q2 24 | $-0.52 | $-0.19 | ||
| Q1 24 | $-0.54 | $-0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $383.3M | $34.1M |
| 总债务越低越好 | — | $547.3M |
| 股东权益账面价值 | $314.7M | $96.9M |
| 总资产 | $842.8M | $1.4B |
| 负债/权益比越低杠杆越低 | — | 5.65× |
8季度趋势，按日历期对齐
现金及短期投资MIRMTE
| Q4 25 | $383.3M | — | ||
| Q3 25 | $375.5M | $34.1M | ||
| Q2 25 | $304.6M | $8.5M | ||
| Q1 25 | $277.7M | $48.9M | ||
| Q4 24 | $280.3M | — | ||
| Q3 24 | $284.4M | $181.9M | ||
| Q2 24 | $278.4M | $219.6M | ||
| Q1 24 | $302.8M | $249.9M |
总债务MIRMTE
| Q4 25 | — | — | ||
| Q3 25 | — | $547.3M | ||
| Q2 25 | — | $591.2M | ||
| Q1 25 | — | $603.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $602.3M |
股东权益MIRMTE
| Q4 25 | $314.7M | — | ||
| Q3 25 | $292.0M | $96.9M | ||
| Q2 25 | $255.2M | $183.9M | ||
| Q1 25 | $233.3M | $201.9M | ||
| Q4 24 | $225.6M | — | ||
| Q3 24 | $232.0M | $538.7M | ||
| Q2 24 | $229.0M | $561.6M | ||
| Q1 24 | $234.6M | $582.3M |
总资产MIRMTE
| Q4 25 | $842.8M | — | ||
| Q3 25 | $785.1M | $1.4B | ||
| Q2 25 | $725.8M | $1.4B | ||
| Q1 25 | $690.2M | $1.4B | ||
| Q4 24 | $670.8M | — | ||
| Q3 24 | $667.9M | $615.0M | ||
| Q2 24 | $660.8M | $644.4M | ||
| Q1 24 | $652.0M | $670.3M |
负债/权益比MIRMTE
| Q4 25 | — | — | ||
| Q3 25 | — | 5.65× | ||
| Q2 25 | — | 3.21× | ||
| Q1 25 | — | 2.99× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.03× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.1M | $63.9M |
| 自由现金流经营现金流 - 资本支出 | $5.5M | $55.0M |
| 自由现金流率自由现金流/营收 | 3.7% | 26.1% |
| 资本支出强度资本支出/营收 | 0.4% | 4.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $54.9M | $-42.3M |
8季度趋势，按日历期对齐
经营现金流MIRMTE
| Q4 25 | $6.1M | — | ||
| Q3 25 | $39.7M | $63.9M | ||
| Q2 25 | $12.0M | $33.4M | ||
| Q1 25 | $-2.0M | $-44.8M | ||
| Q4 24 | $-5.1M | — | ||
| Q3 24 | $4.0M | $-28.4M | ||
| Q2 24 | $-3.8M | $-28.0M | ||
| Q1 24 | $15.2M | $-16.2M |
自由现金流MIRMTE
| Q4 25 | $5.5M | — | ||
| Q3 25 | $39.5M | $55.0M | ||
| Q2 25 | $11.9M | $10.6M | ||
| Q1 25 | $-2.0M | $-74.0M | ||
| Q4 24 | $-5.1M | — | ||
| Q3 24 | $3.8M | $-34.0M | ||
| Q2 24 | $-4.6M | $-35.6M | ||
| Q1 24 | $15.2M | $-37.7M |
自由现金流率MIRMTE
| Q4 25 | 3.7% | — | ||
| Q3 25 | 29.7% | 26.1% | ||
| Q2 25 | 9.3% | 8.0% | ||
| Q1 25 | -1.8% | -138.4% | ||
| Q4 24 | -5.1% | — | ||
| Q3 24 | 4.2% | — | ||
| Q2 24 | -5.9% | — | ||
| Q1 24 | 22.0% | — |
资本支出强度MIRMTE
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.1% | 4.2% | ||
| Q2 25 | 0.1% | 17.2% | ||
| Q1 25 | 0.0% | 54.5% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率MIRMTE
| Q4 25 | — | — | ||
| Q3 25 | 13.66× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MIRM
| Livmarli | $106.4M | 71% |
| Bile Acid Medicines | $42.5M | 29% |
TE
| Related Party | $120.1M | 57% |
| Nonrelated Party | $90.4M | 43% |
